By influencing metabolism and apoptosis, VDAC1 may participate in tumor cells’ adaptation to the IL-17-induced inflammatory milieu, potentially advancing tumor progression and facilitating immune evasion. The gene discussed is VDAC1; the disease is neoplasm.